Life Science Investing PharmAla To Supply Østfold Hospital Trust with LaNeo MDMA for Clinical Research
Life Science Investing PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
Life Science Investing PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
Life Science Investing PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital
Life Science Investing Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
Life Science Investing Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
Skyharbour Announces Additional Uranium Property Staking Increasing Total Portfolio to Over 662,000 Hectares in the Athabasca Basin, Saskatchewan
Homerun Resources Inc. Announces Full Mining Permit and Finalization of the Definitive Lease Agreement With CBPM
Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
